Fig. 3From: Defining the impact of platelet-to-lymphocyte ratio on patient survival with gastric neuroendocrine neoplasm: a retrospective cohort analysisA, B Kaplan–Meier estimate of overall survival of patient with g-NEN according to PLR and BMI (group 1, PLR Q1–Q3 and BMI < 25 kg/m2; group 2, Q1–Q3 and BMI ≥ 25 kg/m2; group 3, PLR Q4 and BMI < 25 kg/m2; and group 4, PLR Q4 and BMI ≥ 25 kg/m2)Back to article page